Table 3.
|
Overlap with LCLs (Dixon et al.) |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
α2 = 0.01 |
α2 = 0.005 |
α2 = 0.001 |
||||||||||
| Dimas et al. | ||||||||||||
| FDR1 = 0.001 | ||||||||||||
| LCLs | 0.368 | 1.000a | 0.312 | 1.000a | 0.241 | 1.000a | ||||||
| Fibroblasts | 0.237 | 0.633 | 0.202 | 0.643 | 0.151 | 0.624 | ||||||
| T cells | 0.257 | 0.690 | 0.230 | 0.732 | 0.167 | 0.691 | ||||||
| FDR1 = 0.005 | ||||||||||||
| LCLs | 0.326 | 1.000a | 0.272 | 1.000a | 0.208 | 1.000a | ||||||
| Fibroblasts | 0.210 | 0.632 | 0.177 | 0.644 | 0.131 | 0.630 | ||||||
| T cells | 0.235 | 0.712 | 0.204 | 0.744 | 0.143 | 0.687 | ||||||
Assumed.